Nutex Health Inc. (NUTX) stock
NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3067% below fair value
$171.41−17.78 (-9.40%)
Close on Nov 12, 2026Market cap $1.17BP/E 7.3Yield –
Nutex Health EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Nutex Health's EV/EBITDA was 3.2× on Nov 11, 2026, against 2.1× a year earlier. Over the last 4 years it ranged from 1.4× to 628.8×, with a median of 12.2×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.2× | +0.2 |
| 2025 | Dec 31, 2025 | 3.0× | −17.3 |
| 2024 | Dec 31, 2024 | 20.3× | −10.7 |
| 2023 | Dec 29, 2023 | 31.0× | +26.6 |
| 2022 | Oct 31, 2022 | 4.4× | −9.9 |
| 2021 | Dec 31, 2021 | 14.3× | – |
See a number that looks wrong?